Alan Brnabic Selected Research

Alan Brnabic Research Topics

5	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2024 - 02/2020
2	Neoplasms (Cancer) 01/2023 - 12/2022
2	Chronic Pain 01/2017 - 06/2013
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023
1	Sarcoma (Soft Tissue Sarcoma) 12/2022
1	Osteoporosis 01/2022
1	Back Pain (Backache) 01/2022
1	Pain (Aches) 06/2013
1	Mania (Manias) 02/2011
1	Parkinson Disease (Parkinson's Disease) 11/2003
1	Vascular Diseases (Vascular Disease) 12/2002
1	Unstable Angina 12/2002
1	Coronary Disease (Coronary Heart Disease) 12/2002

5	ixekizumabIBA 04/2024 - 02/2020
3	secukinumabIBA 04/2024 - 02/2020
3	InterleukinsIBA 04/2024 - 02/2020
2	guselkumabIBA 04/2024 - 02/2020
2	Adalimumab (Humira)FDA Link 04/2024 - 02/2020
2	risankizumabIBA 04/2024 - 02/2020
1	sintilimabIBA 01/2023
1	PlatinumIBA 01/2023
1	Pemetrexed (MTA)FDA Link 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	W 12IBA 11/2022
1	Teriparatide (Parathar)FDA Link 01/2022
1	Certolizumab Pegol FDA Link 02/2020
1	tildrakizumabIBA 02/2020
1	brodalumabIBA 02/2020
1	Etanercept (Enbrel)FDA Link 02/2020
1	Infliximab (Remicade)FDA Link 02/2020
1	Ustekinumab (CNTO 1275)FDA Link 02/2020
1	Tumor Necrosis Factor InhibitorsIBA 02/2020
1	Interleukin-12 (IL 12)IBA 02/2020
1	Interleukin-23 (Interleukin 23)IBA 02/2020
1	Olanzapine (Zyprexa)FDA Link 02/2011
1	Vasopeptidase InhibitorsIBA 12/2002
1	omapatrilatIBA 12/2002